| abstract |
The present invention relates to a new vector for pharmacologically active water-insoluble molecules. These nanovectors, which are in the form of carbon nanoplatforms, are capable of solubilising said active molecules while reducing the side effects of the treatments. The present invention also relates to the processes for synthesizing these nanoplatforms, as well as to the use thereof as a drug, particularly in the treatment of brain tumours. |